Dihexa
Price range: $103.85 through $193.37
EarnΒ 104 – 193Β points upon purchasing this product.
β 99% Purity β Third-Party Tested
π Free U.S. Shipping on Orders $100+
πΊπΈ Proudly Made in the USA
β‘ Fast & Reliable Shipping
π Secure Checkout Guaranteed
Full disclaimer β
β₯99% Purity β HPLC Verified
Dual COA β HPLC + LAL Endotoxin
Unique Lot Numbers β Full Traceability
USA Manufactured & Third-Party Tested
Ships USA in 1 Business Day
QC: 2025-12-01
β₯99.4% HPLC
Buy Dihexa β
β₯99% Purity + Dual COA
When you buy Dihexa from PureRawz, every vial ships with two independent Certificates of Analysis β HPLC purity verification and an LAL endotoxin assay β traceable to a unique batch lot number. ProSpec certifies only 97% purity with zero endotoxin data. SwissChems provides no per-lot LAL testing. PureRawz is the USA-based dual-COA standard. Ships in 1 business day. No prescription required.
LAL Endotoxin Tested
Unique Lot Number
USA Manufactured
Ships in 1 Business Day
per vial Β· free shipping $[THRESHOLD]+
Full Product Specifications
All data verifiable via lot-specific COA documents included with every order.
| Compound Name | Dihexa (PNB-0408) |
| IUPAC / Full Name | N-hexanoic-Tyr-Ile-(6) aminohexanoic amide |
| Synonyms | PNB-0408, N-(1-oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-L-isoleucinamide |
| Amino Acid Sequence | Hexanoyl-Tyr-Ile-Ahx-NHβ |
| Molecular Formula | CββHββNβOβ |
| Molecular Weight | 504.7 g/mol |
| CAS Number | 1401708-83-5 |
| PubChem CID | 129010512 |
| Purity (HPLC) | β₯99% β third-party verified per lot |
| Endotoxin (LAL) | Tested β COA included per lot |
| Physical Appearance | White lyophilised (freeze-dried) powder |
| Solubility | DMSO, sterile water, PBS (β₯100 Β΅g/mL) |
| Storage | β20 Β°C, desiccated, protected from light |
| Stability Note | Lipophilic structure β avoid RT exposure; degrade within 12β18 h at room temp |
| Shelf Life | 36 months under proper storage |
| Lot Traceability | Unique lot number β every vial, every batch |
| Manufacturing | USA (domestic synthesis and lyophilisation) |
| Testing | Independent third-party laboratory |
| Shipping | 1 business day Β· USA domestic only |
| Intended Use | In-vitro laboratory research only |
Why PureRawz Provides a Dual COA β And Why It Matters for Dihexa Research
ProSpec certifies only 97% purity by RP-HPLC with no endotoxin data β and ships at room temperature. SwissChems provides no per-lot purity statement or LAL data on its Dihexa page. PureRawz issues two separate, lot-specific COAs on every batch β because Dihexa's c-Met phosphorylation, spinogenesis, and cell-viability assays are the exact assay types most severely corrupted by trace endotoxin contamination.
HPLC Purity Certificate
High-Performance Liquid Chromatography separates and quantifies every molecular species in the sample. PureRawz Dihexa consistently measures β₯99% purity per lot β versus ProSpec's 97% RP-HPLC standard. For c-Met binding assays performed at picomolar concentrations, a 2% impurity difference can produce measurable false-signal artefacts. The full chromatogram PDF is available for download with every order.
β₯99% purity confirmed per lot
LAL Endotoxin Assay Certificate
The Limulus Amebocyte Lysate (LAL) assay detects bacterial LPS that HPLC cannot identify. Dihexa is studied at picomolar concentrations in spinogenesis and c-Met phosphorylation assays β the same concentration range at which sub-nanogram LPS activates TLR4 on microglia and macrophages, producing false neuroinflammatory signals. A clean LAL COA is the only safeguard. Neither ProSpec nor SwissChems provides this documentation per lot.
LAL endotoxin tested β per lot
Both COA documents are lot-number-specific. Download from the product page or retrieve via officialpurerawz.us/verify.
What Is Dihexa?
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide; CAS 1401708-83-5) is a synthetic oligopeptide derived from angiotensin IV (AngIV) β a hexapeptide fragment of the renin-angiotensin system known to influence cognitive function via central nervous system receptors. It was developed at Washington State University by Dr. Joseph W. Harding's laboratory through systematic structural modification of the AngIV analog NleΒΉ-AngIV, with the explicit goal of creating an orally active, blood-brain barrier-penetrant compound with metabolic stability far exceeding that of its endogenous parent.
The key structural modifications β addition of a hexanoyl (N-hexanoic acid) group at the N-terminus and replacement of the C-terminal carboxyl with a 6-aminohexanoic amide β dramatically increase lipophilicity and reduce enzymatic vulnerability. In preclinical pharmacokinetic models, these changes extend plasma half-life to approximately 335 minutes, compared to minutes for AngIV itself. Dihexa's lipophilicity also enables it to achieve brain-to-plasma concentration ratios exceeding 1.0 following oral administration in rodent models.
Dihexa's primary research interest lies in its mechanism: it functions as an allosteric potentiator of hepatocyte growth factor (HGF), binding HGF with a dissociation constant of approximately 65 picomolar and amplifying HGF's ability to activate the c-Met receptor tyrosine kinase. This makes it a unique tool for studying synaptogenesis, dendritic spine density, and structural plasticity in isolation from neurotransmitter modulation pathways.
Important research note: The 2014 Benoist et al. paper (J Pharmacol Exp Ther) establishing the HGF/c-Met mechanism was retracted in April 2025 due to image integrity concerns. However, an independent 2021 study (Chai et al., Brain Sciences) confirmed cognitive improvements in APP/PS1 Alzheimer's transgenic mice via the PI3K/Akt signalling pathway and remains in good standing. Researchers should cite current literature accordingly.
Mechanism of Action β Six Research Pathways
All findings are from in-vitro or animal studies only. Researchers should note the 2025 retraction of Benoist et al. (2014) and should rely on post-2021 independent literature for citation purposes.
Dihexa binds hepatocyte growth factor (HGF) with high affinity (Kd ~65 pM) at the hinge region, facilitating HGF dimerisation β a prerequisite for c-Met receptor binding and activation. In the presence of subthreshold HGF concentrations, Dihexa restores full c-Met phosphorylation, augmenting HGF-dependent cell scattering and intracellular kinase cascades in HEK-293T cell models.
Harding lab, WSU; Chai et al., Brain Sciences 2021 [1]
In dissociated hippocampal neuron cultures, Dihexa at picomolar concentrations induces dendritic spinogenesis and synaptogenesis equivalent to suprathreshold HGF. Post-mortem hippocampal analyses in rodent models report dendritic spine density increases of 40β60% in CA1 and dentate gyrus, with electron microscopy confirming functional synapse formation including presynaptic vesicle clustering and postsynaptic density maturation.
Independent preclinical literature; Chai et al. 2021 [1]
c-Met activation by Dihexa triggers the PI3K/Akt intracellular pathway β a major pro-survival, anti-apoptotic signalling axis. In the APP/PS1 Alzheimer's transgenic mouse model (Chai et al., 2021), Dihexa restored spatial learning and cognitive function via this pathway, with improved Morris water maze performance correlating with hippocampal Akt phosphorylation levels.
Chai et al., Brain Sciences 2021 [1]
The MAPK/ERK cascade, activated downstream of c-Met, translocates to the nucleus and upregulates transcription factors (CREB, Elk-1) driving expression of structural synaptic proteins β PSD-95 (postsynaptic density scaffolding), synaptophysin (presynaptic vesicle marker), spinophilin, and GAP-43 (axonal sprouting). Histological analyses confirm elevated expression of these markers in hippocampal CA1 and dentate gyrus following Dihexa administration.
Preclinical histological analyses, multiple models
Dihexa augments hippocampal long-term potentiation β the synaptic strengthening mechanism underlying memory consolidation β in aged rodent models (18β24 months), restoring LTP amplitudes to levels observed in young adult animals. Cognitive benefits in preclinical models persist 2β4 weeks after treatment cessation, consistent with stable structural synaptic changes rather than transient neurotransmitter modulation.
Rodent LTP studies, Harding lab literature
In controlled cortical impact TBI models in rats, Dihexa administration beginning 24 hours post-injury reduced lesion volume by 25β30% and improved motor coordination recovery (rotarod). Immunohistochemistry revealed increased doublecortin (neurogenesis marker) in the SVZ and dentate gyrus, alongside reduced Iba1-positive activated microglia in perilesional cortex β suggesting both neurogenic and anti-inflammatory research dimensions.
TBI preclinical model literature
Batch Traceability β Our Public Lot Verification Portal
ProSpec ships Dihexa at room temperature with 97% purity and no endotoxin data. SwissChems provides no per-lot COA for Dihexa on their product page. PureRawz provides full per-lot documentation β publicly verifiable β because Dihexa's extreme picomolar potency makes batch integrity non-negotiable for reproducible research.
Every vial is traceable to a specific, independently tested batch.
Enter the lot number printed on your vial at officialpurerawz.us/verify and retrieve:
- The HPLC purity COA PDF for your exact batch
- The LAL endotoxin COA PDF for your exact batch
- The name of the independent third-party testing laboratory
- The QC release date and synthesis batch ID
- Documentation suitable for IRB submissions and publication methodology sections
DX-2025-0089
Verify at /verify β
PureRawz vs. Competitors β Dihexa Side-by-Side
Based on publicly available supplier information as of April 2026.
| Feature | PureRawz β¦ | ProSpec Bio | SwissChems |
|---|---|---|---|
| Purity Standard | β₯99% HPLC | Only 97% RP-HPLC | Not stated per lot |
| HPLC Purity COA | β Per lot β downloadable PDF | RP-HPLC listed on page | β No Dihexa-specific COA shown |
| LAL Endotoxin COA | β Per lot β full assay | β Not provided | β Not provided |
| Unique Lot Number Per Vial | β Every vial | β Not mentioned | β Not mentioned |
| Public Lot Verification Portal | β officialpurerawz.us/verify | β | β |
| USA Based / USA Shipping | β Domestic USA only | β Israel-based | β Iceland-based (.is domain) |
| Ships in 1 Business Day (USA) | β | β International transit | β International transit |
| Cold-Chain Shipping | β | β Ships at room temp | Not stated |
| Trust Badge Strip on Page | β 5 badges | β None | 2 basic badges |
| FAQ Section (Schema Rich Results) | β 10 Q&As | β | β |
| Research Background on Page | β Full MOA + refs | Brief background only | β Generic compound description |
| No Prescription Required | β | β | β |
| HPLC Refund Guarantee | β | β Not stated | β |
β¦ PureRawz. Data from publicly available pages, April 2026. Subject to change.
Researchers Studying Dihexa Also Explore
Dihexa Research FAQ
For research and educational purposes only. Nothing here constitutes medical advice.
References
- Chai S-Y et al. AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling Pathway. Brain Sciences. 2021;11(12):1555. PMID: 34827487 β Independent confirmation; currently in good standing.
- McCoy AT et al. Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents. J Pharmacol Exp Ther. 2013;344(1):141β154. PMID: 23076063 β Expression of concern issued; not retracted.
- Benoist CC et al. Cognition-enhancing and neuroprotective activity of a novel angiotensin IV analog. J Pharmacol Exp Ther. 2014. PMID: 25187433 β Retracted April 2025. Cited here for historical context only.
- Wright JW, Harding JW. The brain hepatocyte growth factor/c-Met receptor system: a new target for the treatment of Alzheimer's disease. J Alzheimers Dis. 2015;45(4):985β1000. PMID: 25633668
- Harding JW et al. Facilitation of the Brain HGF/c-Met Receptor System: A New Approach to Treat Alzheimer's Disease? Austin J Clin Neurol. 2016;3(1):1086.
Dihexa
Dihexa is a powerful nootropic research compound commonly explored for cognitive enhancement, memory studies, neurogenesis support, and advanced laboratory applications.
Browse related Purerawz products and trusted scientific references below.
Related Products
- Buy Semax β focus and memory support studies
- Buy Selank β mood and nootropic support research
- Buy NSI-189 β neurogenesis and cognitive research
- Buy Bromantane β advanced cognitive performance support
- Buy Epithalon β longevity and peptide research
- Buy MK-677 β recovery and growth support research
Research References
-
PubMed Research Database
β scientific studies and published research -
National Center for Biotechnology Information (NCBI)
β biomedical and research resources -
U.S. Food and Drug Administration
β regulatory and compliance reference
Additional information
| Attributes | Powder 500mg, Powder 1000mg, Liquid 30ml/17mg per ml/500mg, Tablets 20mg per tablet/27ct/540mg, Tablets 20mg per tablet/54ct/1080mg |
|---|





Reviews
There are no reviews yet.